In fact, companies like Pfizer and Amgen recently have spent more money in buying back their shares to boost their stock price than on R&D, but that's a whole different TED Talk which one day I'd be fascinated to tell you about.
De hecho, empresas como Pfizer y Amgen recientemente gastaron mucho más dinero recomprando sus acciones para subirles el precio, que en I+D, pero esa es una charla TED que otro día me fascinaría dar.